PIL - Atazanavir Accord 200mg, 300mg Hard Capsules: Change history
View Patient Information Leaflet (PIL - Atazanavir Accord 200mg, 300mg Hard Capsules)
Last updated on this site: 18 Sep 2023
Description of update: The proposed change is: C.I.2.a; update sections 4.4, 4.5, 4.6, 4.8 of SmPC and section 2 of the leaflet in line with the Reference product (Reyataz 100mg/150mg/200mg/300mg Hard Capsules; MAH: Bristol-Myers Squibb Pharmaceuticals limited; EMA procedure number: EMEA/H/C/000494/IB/0136 updated on 17/10/2022).
PIL sections updated: 2, 4 and 6.
Last updated on this site: 18 Sep 2023
Description of update: The proposed change is: C.I.2.a; update sections 4.4, 4.5, 4.6, 4.8 of SmPC and section 2 of the leaflet in line with the Reference product (Reyataz 100mg/150mg/200mg/300mg Hard Capsules; MAH: Bristol-Myers Squibb Pharmaceuticals limited; EMA procedure number: EMEA/H/C/000494/IB/0136 updated on 17/10/2022).
PIL sections updated: 2, 4 and 6.
-
Changes: (Updated: 18 Sep 2023)
Description of update: The proposed change is: C.I.2.a; update sections 4.4, 4.5, 4.6, 4.8 of SmPC and section 2 of the leaflet in line with the Reference product (Reyataz 100mg/150mg/200mg/300mg Hard Capsules; MAH: Bristol-Myers Squibb Pharmaceuticals limited; EMA procedure number: EMEA/H/C/000494/IB/0136 updated on 17/10/2022).
PIL sections updated: 2, 4 and 6.
-
Changes: (Updated: 20 Sep 2022)
Initial upload